BBI
ELV icon

Baxter Bros Inc’s Elevance Health ELV Stock Holding History

Baxter Bros Inc’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Buy
+617
New +$229K 0.03% 155
2026
Q1 		– Sell
-921
Closed -$323K – 172
2025
Q4 		$323K Hold
921
– – 0.04% 134
2025
Q3 		$298K Buy
+921
New +$286K 0.03% 143
2025
Q1 		– Sell
-868
Closed -$320K – 153
2024
Q4 		$320K Sell
868
-240
-22% -$100K 0.04% 127
2024
Q3 		$576K Sell
1,108
-1
-0.1% -$534 0.07% 100
2024
Q2 		$601K Sell
1,109
-200
-15% -$106K 0.08% 94
2024
Q1 		$679K Buy
1,309
+25
+2% +$12.4K 0.09% 93
2023
Q4 		$605K Buy
1,284
+184
+17% +$85.1K 0.08% 97
2023
Q3 		$479K Buy
+1,100
New +$499K 0.07% 103

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baxter Bros Inc's ELV Position: Q2 2026 in Review

Baxter Bros Inc opened a new position in Elevance Health (ELV) in Q2 2026: 617 shares worth $239K. The stake represents 0.03% of the portfolio and ranks #155 among its holdings. This is a return to the name: Baxter Bros Inc previously reported a position in ELV as recently as Q4 2025.

Baxter Bros Inc first reported a position in ELV in Q3 2023 and has held it in 9 quarters since. The position peaked at $679K in Q1 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Baxter Bros Inc held 617 shares of Elevance Health worth $239K as of Q2 2026.
  • Elevance Health was a new Baxter Bros Inc position in Q2 2026.
  • Elevance Health made up 0.03% of Baxter Bros Inc's portfolio in Q2 2026, its #155 holding.
  • Baxter Bros Inc first reported a position in Elevance Health in Q3 2023 and has held it in 9 quarters since.
  • Baxter Bros Inc's Elevance Health position peaked at $679K in Q1 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Baxter Bros Inc's 13F filing for Q2 2026, filed 6 Aug 2026.